We are live on ! Find out more
EBAC

European Biotech Acquisition Corp. Class A Ordinary Shares

Delisted

EBAC was delisted on the 2nd of March, 2023.

Name Holding Trade Value Shares
Change
Change in
Stake
GCL
1
Glazer Capital LLC
New York
$12.7M +$2.59M +259,259 +26%
PC
2
Periscope Capital
Ontario, Canada
$7.85M -$664K -66,426 -8%
Millennium Management
3
Millennium Management
New York
$5.99M -$35.5K -3,554 -0.6%
Macquarie Group
4
Macquarie Group
Australia
$5.09M
LA
5
Linden Advisors
New York
$5.03M
Marshall Wace
6
Marshall Wace
United Kingdom
$4.59M
D.E. Shaw & Co
7
D.E. Shaw & Co
New York
$4.13M +$1.5M +150,000 +58%
TCSAM
8
Tyrus Capital S.A.M.
Monaco
$4.04M +$4M +400,000 New
WP
9
Woodline Partners
California
$3.79M +$999K +100,000 +36%
SC
10
Sculptor Capital
New York
$3.56M
RCM
11
Radcliffe Capital Management
Pennsylvania
$3.12M +$952K +95,242 +45%
PMAM
12
Picton Mahoney Asset Management
Ontario, Canada
$2.78M
Bank of America
13
Bank of America
North Carolina
$2.63M
FTCM
14
First Trust Capital Management
Illinois
$2.59M +$278K +27,827 +12%
MI
15
MMCAP International
Cayman Islands
$2.52M
MF
16
Magnetar Financial
Illinois
$2.33M
AA
17
AQR Arbitrage
Connecticut
$2.02M
KL
18
KIM LLC
Kansas
$2.02M
Alyeska Investment Group
19
Alyeska Investment Group
Illinois
$1.51M
MCM
20
Moore Capital Management
New York
$1.26M
FTCM
21
Fir Tree Capital Management
New York
$1.07M
State of Wisconsin Investment Board
22
State of Wisconsin Investment Board
Wisconsin
$1.02M
TCM
23
Tenor Capital Management
New York
$1.01M
MTCM
24
Mint Tower Capital Management
Netherlands
$1.01M +$999K +100,000 New
Hudson Bay Capital Management
25
Hudson Bay Capital Management
Connecticut
$1.01M